Infectious Disease

 
How Physicians Can Strengthen Vaccine Confidence During National Immunization Awareness Month
August 08, 2025

Board-certified family physician Sarah Sams, MD, urges physicians to actively engage their communities to build vaccine confidence and combat misinformation.

Reframing Vaccines as Innovation: A Strategy to Rebuild Patient Trust in Primary Care
August 07, 2025

Infectious disease physician Amesh Adalja, MD, explains how PCPs can reframe vaccines as health technology to boost confidence and counter hesitancy.

11 US Vaccine Policy Updates: How Will They Affect Your Practice?
August 06, 2025

Since his senate approval as head of HHS in February, RFK Jr has enacted and/or proposed seismic changes to US vaccine policy that will impact your daily care of patients.

The Biggest Threat to Vaccine Confidence in the US: An Expert Discussion
August 06, 2025

Amesh Adalja, MD, urges physicians to use their trusted position to counter widespread vaccine misinformation and strengthen patient confidence in immunization.

When Guidelines Diverge: Navigating Vaccine Recommendations in 2025
August 05, 2025

Amesh Adalja, MD, advises physicians turn to specialty societies for evidence-based, reliable recommendations this respiratory virus season.

Amesh Adalja, MD, on How PCPs Can Counter Social Media Vaccine Misinformation
August 04, 2025

Amesh Adalja, MD, explains how physicians can rebut social media vaccine claims with concise, referenced facts and patient-centered communication.

Amesh Adalja, MD, on How to Defuse Vaccine Safety Concerns Without Derailing the Visit
July 31, 2025

Dr Adalja offers evidence-based strategies to address patient concerns about aluminum and thimerosal in vaccines.

Amesh Adalja, MD, Breaks Down 2025 Vaccine Policy Shifts for Primary Care
July 30, 2025

Infectious disease expert Amesh Adalja, MD, outlines the biggest vaccine policy shifts of 2025, including changes to COVID-19 and flu vaccine recommendations.

Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds
July 25, 2025

Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.

Influenza Vaccination Reduces Disease Burden in Both Vaccinated and Unvaccinated, Modeling Study Finds
July 24, 2025

Vaccination lowered influenza cases by about 33% to 42% in seasonal flu setups with 40% vaccine effectiveness, researchers reported.